Clinical Trial: Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala

Brief Summary: The purpose of this study is to determine whether rifampin and/or azithromycin are effective in the treatment of river blindness (onchocerciasis).